Thomas Johnson

Aug 9, 2024 | jamanetwork.com | Angela Liu |Kelly Anderson |Joseph Levy |Thomas Johnson

Key PointsQuestion  Does Medicare Advantage step therapy change prescribing patterns for macular degeneration physician-administered drugs?

Sep 1, 2023 | glaucomaphysician.net | Thomas Johnson

This is an exciting time for regenerative medicine, especially as it relates to ophthalmology. Diseases of the retina and optic nerve have long been considered treatable but incurable. Anti-VEGF therapy revolutionized our field by enabling vision improvement through resolution of cystoid macular edema or subretinal fluid in conditions such as diabetic retinopathy, neovascular age-related macular degeneration, and retinal vascular occlusion.